Commercial Life Sciences
Enablement as a Service™ Across the Regulated Spectrum
25RevolAI serves the full commercial life sciences ecosystem, offering a structured alternative to legacy models. Whether a life sciences incubator is building compliance infrastructure for its cohort, an early-stage medtech company is navigating its first 510(k) submission, or an established clinical lab is managing CLIA and CAP compliance, the traditional Dependency as a Service™ model inevitably introduces systemic inefficiencies that our solution eliminates.
The Dependency as a Service™ pattern shows up differently at each stage of your organization's journey. Find yours.
| The Problem You're Experiencing | DaaS Pattern | Our Approach |
|---|---|---|
| We bought a platform and it still required a team of consultants | Platform Dependency | Ground Truth OS™ structured handoff |
| Our AI pilot never made it past legal and compliance review | Approval Paralysis | Compliance-first architecture from day one |
| We can't get a clear answer on what AI actually does with our data | Data Opacity | Full audit trail, explainable outputs |
| Our regulatory team and AI vendor can't communicate effectively | Practitioner Disconnect | Practitioner-led engagement model |
Build shared compliance infrastructure for your portfolio companies. Ground Truth OS™ scales across cohorts.
Navigate IND, BLA, and NDA preparation with practitioner-led AI that understands the science behind the submission.
510(k), De Novo, and PMA pathways supported. AI-assisted design history file management and risk documentation.
CLIA and CAP compliance, LDT regulatory positioning, and laboratory information system integration.
EU IVDR and FDA 510(k)/PMA for in vitro diagnostics. Regulatory strategy through submission dossier.
GMP compliance, CMC documentation, and clinical data management. Support for both sponsor-facing and internal quality workflows.
See your specific regulatory workflow automated before any financial or contractual commitment.
AI-generated, practitioner-reviewed documentation that meets FDA, CE, and international submission standards.
The operating layer for regulated AI: version-controlled, audit-ready, and fully platform-agnostic.
A structured implementation plan paired with thorough knowledge transfer ensures you own the final outcome rather than a perpetual subscription.
No commitment. A working prototype before any financial obligation.